VisageX Medical

Company Overview

Snapshot

Founded in March 2022 by Gideon Meyer Brodnitz, VisageX Medical operates with 1–10 employees. The company has raised $1.45M across four funding rounds. VisageX Medical is currently conducting its First-in-Human (FIH) study for its adjustable facial implants.

Business overview

VisageX Medical is pioneering a new category in medical implants with its Adjustable Permanent Implants (API), which are smart, programmable implants designed to be reshaped non-invasively after implantation using induction heating of shape memory materials. The company's platform aims to address various clinical applications, including reconstructive, aesthetic, cranial, orthopedic, urological, and ENT indications. Its initial focus is on facial reconstructive implants for craniomaxillofacial (CMF) surgery, where current static implants often necessitate revisions. VisageX Medical serves the healthcare industry, specifically targeting providers within the Health Tech & Life Sciences sector.

Company Intelligence Q&A

What is VisageX Medical's core product offering?

VisageX Medical develops Adjustable Permanent Implants (API), which are smart, programmable medical implants that can be reshaped non-invasively after surgical implantation using induction heating. These implants are initially focused on facial reconstructive applications.

When was VisageX Medical founded?

VisageX Medical was founded in March 2022.

Who is the founder of VisageX Medical?

Gideon Meyer Brodnitz is the Co-founder and CEO of VisageX Medical.

What is the primary sector VisageX Medical operates in?

VisageX Medical operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Biomaterials & Tissue Engineering.

What is the current product development stage for VisageX Medical?

VisageX Medical's products are currently in the clinical trial stage, with the company having started its First-in-Human (FIH) study.